Literature DB >> 24810176

Acute dacryocystitis: another clinical manifestation of sporotrichosis.

Dayvison Francis Saraiva Freitas1, Iluska Augusta Rocha Lima2, Carolina Lemos Curi3, Livia Jordão3, Rosely Maria Zancopé-Oliveira4, Antonio Carlos Francesconi do Valle1, Maria Clara Gutierrez Galhardo1, Andre Luiz Land Curi2.   

Abstract

Sporotrichosis associated with exposure to domestic cats is hyperendemic in Rio de Janeiro, Brazil. A review of the clinical records at our institute revealed four patients with clinical signs of dacryocystitis and a positive conjunctival culture for Sporothrix who were diagnosed with Sporothrix dacryocystitis. Three patients were children (< 13 years of age) and one patient was an adult. Two patients reported contact with a cat that had sporotrichosis. Dacryocystitis was associated with nodular, ulcerated lesions on the face of one patient and with granulomatous conjunctivitis in two patients; however, this condition manifested as an isolated disease in another patient. All of the patients were cured of the fungal infections, but three patients had chronic dacryocystitis and one patient developed a cutaneous fistula. Sporotrichosis is usually a benign disease, but may cause severe complications when the eye and the adnexa are affected. Physicians, especially ophthalmologists in endemic areas, should be aware of the ophthalmological manifestations and complications of sporotrichosis.

Entities:  

Mesh:

Year:  2014        PMID: 24810176      PMCID: PMC4015260          DOI: 10.1590/0074-0276130304

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


Sporothrix schenckii is a dimorphic fungus that is responsible for cutaneous disease in endemic areas worldwide. Classically, infection is associated with a traumatic subcutaneous inoculation of contaminated soil, plants or organic matter. The most common clinical form of sporotrichosis is cutaneous, lymphatic disease, which accounts for 75% of cases, followed by localised cutaneous forms (20%) (Barros et al. 2011a). Ocular sporotrichosis has rarely been described in immunocompetent patients or in individuals without prior ocular trauma. Intraocular disease has an important association with disseminated disease (Curi et al. 2003, Iyengar et al. 2010, Kashima et al. 2010). Acute dacryocystitis presents as inflammation of the lacrimal sac and is typically caused by infection. Dacryocystitis is predominantly found in adult women and in young infants. The most common signs and symptoms include erythema, oedema and a painful area of induration that overlies the nasolacrimal sac just below the anatomical boundary of the medial canthal ligament. In addition, epiphora and discharge may be observed. When pressure is applied to the inflamed tear duct, purulent material may be expressed through the lacrimal punctum (Pinar-Sueiro et al. 2012). Cases of isolated granulomatous conjunctivitis due to Sporothrix infection after exposure to cats with sporotrichosis have been reported in Rio de Janeiro (RJ), Brazil (Barros et al. 2004, Schubach et al. 2005). In this study, we evaluated cases of dacryocystitis secondary to Sporothrix infection in this hyperendemic area. This study was approved by the Ethical Committee of the Evandro Chagas Institute of Clinical Research (IPEC)/Oswaldo Cruz Foundation (Fiocruz), RJ, Brazil (0024.0.009.000-10). The authors reviewed the clinical records of patients who were diagnosed with dacryocystitis secondary to Sporothrix infection in the dermatology and ophthalmology laboratories of IPEC/Fiocruz from July 2008-July 2010. Patients underwent dermatological and ophthalmological examinations, including visual acuity (Snellen chart), biomicroscopy and ophthalmoscopy. The patients were initially found to be free of chronic stenosis and epiphora. During this period, 2,146 patients were diagnosed with sporotrichosis and sporotrichosis with dacryocystitis was identified in four patients (Table). Three patients were children (< 13 years of age) and one patient was an adult (41 years of age). The patients sought medical attention at a median time period of five weeks (3-8 weeks) after the initial manifestations of sporotrichosis. Patients 1 and 4 had a history of contact with cats that had sporotrichosis. Dacryocystitis was present at the outset in all cases. One child had cutaneous nodules and ulcerated skin lesions that were culture-positive for Sporothrix (Supplementary data), whereas the other two children had conjunctivitis, but no skin lesions. The adult patient presented only with dacryocystitis (Supplementary data).
TABLE

Clinical characteristics of the patients with Sporothrix dacryocystitis, including whether or not there were additional disease manifestations as well as the patients’ treatment regimens and complications of their disease

Case Sex/age Site of lesion Treatment (ITC) and length (weeks) Follow up
1 F/2 Right dacryocystitis + cutaneous nodule- ulcerated lesions on the face 5 mg/kg (13) Chronic dacryocystitis
2 M/5 Right dacryocystitis + conjunctivitis 100 mg (4) Chronic dacryocystitis
3 F/13 Right dacryocystitis + conjunctivitis 100 mg (12) Chronic dacryocystitis
4 F/41 Left dacryocystitis Up to 400 mg (96) Cutaneous fistula

F: female; ITC: itraconazole; M: male.

F: female; ITC: itraconazole; M: male. The diagnosis of dacryocystitis was established by the presence of swelling at the medial canthus with erythema, epiphora and mucopurulent discharge from the lacrimal punctum. Sporothrix infection was confirmed by the isolation of the fungus in culture using the mucopurulent material that was expressed from the lacrimal punctum, which was obtained by swabbing. Cultures were confirmed as positive for Sporothrix using previously described methods (Barros et al. 2004). Treatment included itraconazole (ITC) 100 mg/day or 5 mg/kg in children who weighed less than 20 kg. This regimen has been highly successful at our institution as previously described (Galhardo et al. 2008, Barros et al. 2011a, b). Blood count and blood biochemistry tests were conducted at baseline, 12 weeks and when clinically necessary. A clinical cure was defined as the resolution of inflammation and a negative follow-up culture. Treatment failure was defined as the persistence or worsening of the initial lesion after 12 weeks of treatment, which occurred in the adult patient who received an escalated dose of ITC to 400 mg/day. The treatment of this patient was significantly prolonged (96 weeks). Case 2 was initially lost to follow-up after four weeks of treatment; however, this patient returned seven months later with chronic dacryocystitis and no mycological findings of sporotrichosis. The other children were treated for 12 and 13 weeks. Follow-up was conducted at a minimum of six months after the end of treatment. Despite mycological cures, the three children had chronic dacryocystitis and the adult patient developed a cutaneous fistula. These patients were referred to surgical treatment. Dacryocystitis secondary to sporotrichosis represented 0.18% of the sporotrichosis cases that were evaluated at the IPEC from July 2008-July 2010. The patients resided in a hyperendemic region for the zoonotic transmission of sporotrichosis and two of the patients had domiciliary contact with cats that had sporotrichosis; however, no specific history of injury was elucidated. Sporotrichosis lesions in cats are rich in parasites and respiratory symptoms can manifest in cats with nasal disease (Schubach et al. 2004, Barros et al. 2011a). Therefore, transmission from cats to humans may occur via respiratory secretions without disruption of the skin barrier when individuals have close face-to-face contact with animals during play (Barros et al. 2004, 2011a). Fungi have been reported to be present in 4-7% of dacryocystitis cases. The most commonly isolated genus is Candida, followed by Aspergillus and Mucor. These cases are generally chronic (Pinar-Sueiro et al. 2012). Sporotrichosis with acute dacryocystitis was observed in the cases in this study. Three of the cases were associated with other clinical manifestations (granulomatous conjunctivitis and lymphocutaneous disease). Granulomatous conjunctivitis has been described in 2.2% of patients with cat associated sporotrichosis in RJ (Barros et al. 2004). Notably, dacryocystitis was identified in one of the 81 cases of sporotrichosis in children presented in a previous analysis of patients in RJ (Barros et al. 2008). Dacryocystitis is an unusual manifestation of sporotrichosis; however, these three cases under the age of 13 in the present study represented 2.2% of the paediatric cases of sporotrichosis at the institution, from July 2008-July 2010. Several studies have found that the face is the most frequently affected site of sporotrichosis in children, which is most likely due to the thinner, more delicate skin in this area of the body (da Rosa et al. 2005). Therefore, children are at an increased risk for this clinical form due to the aerosol mode of transmission from nasally infected cats. The patients in this study responded to treatment; however, each patient had persistent complications that required surgical correction (chronic dacryocystitis and a fistula). Further studies are needed to determine whether dacryocystitis due to Sporothrix infection routinely leads to chronic disease. The pathogenesis of this disease is likely due to Sporothrix infection through the conjunctiva into the lacrimal sac rather than a haematogenous route. We identified two additional patients in the sporotrichosis cohort in this study who presented with dacryocystitis, but these patients were excluded because their lacrimal cultures were negative. However, both patients developed complications, including a fistula and chronic dacryocystitis. Recently, S. schenckii was found to be a complex of species, including Sporothrix brasiliensis, which has been implicated in the hyperendemic transmission of sporotrichosis in RJ (Marimon et al. 2007). The epidemic is associated with the enhanced virulence of the emerging strains of S. brasiliensis (Arrillaga-Moncrieff et al. 2009). A molecular analysis of the strains in these four cases was not performed; however, based on epidemiology, it is likely that S. brasiliensis was the species involved. In conclusion, sporotrichosis is frequently a benign disease; however, extracutaneous manifestations, such as diseases that affect the eye and the adnexa, can lead to severe and chronic complications. Clinicians, particularly ophthalmologists and internists in highly endemic areas, should be aware of the protean manifestations of sporotrichosis.
  14 in total

1.  Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998-2001).

Authors:  Tânia M P Schubach; Armando Schubach; Thais Okamoto; Mônica B L Barros; Fabiano Borges Figueiredo; Tullia Cuzzi; Paulo C Fialho-Monteiro; Rosani S Reis; Mauricio A Perez; Bodo Wanke
Journal:  J Am Vet Med Assoc       Date:  2004-05-15       Impact factor: 1.936

2.  Dacryocystitis: Systematic Approach to Diagnosis and Therapy.

Authors:  Sergio Pinar-Sueiro; Mercedes Sota; Telmo-Xabier Lerchundi; Ane Gibelalde; Bárbara Berasategui; Begoña Vilar; Jose Luis Hernandez
Journal:  Curr Infect Dis Rep       Date:  2012-01-29       Impact factor: 3.725

3.  Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil.

Authors:  Maria Clara Gutierrez Galhardo; Rosely Maria Zancopé De Oliveira; Antonio Carlos Francesconi Do Valle; Rodrigo De Almeida Paes; Patricia Morais E Silvatavares; Araceli Monzon; Emilia Mellado; Juan L Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  Med Mycol       Date:  2008-03       Impact factor: 4.076

Review 4.  Epidemiology of sporotrichosis: a study of 304 cases in Brazil.

Authors:  Ana Cecília Michel da Rosa; Maria Lúcia Scroferneker; Rodrigo Vettorato; Roberto Lopes Gervini; Gerson Vettorato; Analupe Weber
Journal:  J Am Acad Dermatol       Date:  2005-03       Impact factor: 11.527

Review 5.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

6.  Cutaneous Sporothrix schenckii of the human eyelid.

Authors:  Srinivas S Iyengar; Jemshed A Khan; Michael Brusco; Curtis J FitzSimmons
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2010 Jul-Aug       Impact factor: 1.746

7.  Different virulence levels of the species of Sporothrix in a murine model.

Authors:  I Arrillaga-Moncrieff; J Capilla; E Mayayo; R Marimon; M Mariné; J Gené; J Cano; J Guarro
Journal:  Clin Microbiol Infect       Date:  2009-07-14       Impact factor: 8.067

8.  Endemic of zoonotic sporotrichosis: profile of cases in children.

Authors:  Mônica Bastos de Lima Barros; Débora Lúcia Macedo Alves Costa; Tânia Maria Pacheco Schubach; Antônio Carlos Francesconi do Valle; Noemi Pereira Lorenzi; José Liporage Teixeira; Armando de Oliveira Schubach
Journal:  Pediatr Infect Dis J       Date:  2008-03       Impact factor: 2.129

9.  Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases.

Authors:  Monica Bastos de Lima Barros; Armando de Oliveira Schubach; Antônio Carlos Francesconi do Valle; Maria Clara Gutierrez Galhardo; Fátima Conceição-Silva; Tânia Maria Pacheco Schubach; Rosani Santos Reis; Bodo Wanke; Keyla Belizia Feldman Marzochi; Maria José Conceição
Journal:  Clin Infect Dis       Date:  2004-01-29       Impact factor: 9.079

10.  Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest.

Authors:  Rita Marimon; Josep Cano; Josepa Gené; Deanna A Sutton; Masako Kawasaki; Josep Guarro
Journal:  J Clin Microbiol       Date:  2007-08-08       Impact factor: 5.948

View more
  11 in total

1.  Human sporotrichosis: recommendations from the Brazilian Society of Dermatology for the clinical, diagnostic and therapeutic management.

Authors:  Rosane Orofino-Costa; Dayvison Francis Saraiva Freitas; Andréa Reis Bernardes-Engemann; Anderson Messias Rodrigues; Carolina Talhari; Claudia Elise Ferraz; John Verrinder Veasey; Leonardo Quintella; Maria Silvia Laborne Alves de Sousa; Rodrigo Vettorato; Rodrigo de Almeida-Paes; Priscila Marques de Macedo
Journal:  An Bras Dermatol       Date:  2022-09-22       Impact factor: 2.113

2.  Ocular Sporotrichosis.

Authors:  Camila Rodrigues Ribeiro; Bianca Portal Silva; Amanda de Alcantara Almeida Costa; Alberto Basile Neto; Luiz Antônio Vieira; Mônica Aparecida de Lima; Mario Henrique Camargos de Lima
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-06

3.  Ocular sporotrichosis: A frequently misdiagnosed cause of granulomatous conjunctivitis in epidemic areas.

Authors:  João Paulo M Yamagata; Fabiana B Rudolph; Maria Clara L Nobre; Leninha V Nascimento; Felipe Maurício S Sampaio; Andrea Arinelli; Dayvison F Freitas
Journal:  Am J Ophthalmol Case Rep       Date:  2017-09-23

4.  Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics.

Authors:  Rosane Orofino-Costa; Priscila Marques de Macedo; Anderson Messias Rodrigues; Andréa Reis Bernardes-Engemann
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

5.  A Case of Acute Granulomatous Conjunctivitis Caused by Cat-transmitted Sporothrix schenckii.

Authors:  Jiunn Loong L Ling; Koon Ling Koh; Evelyn Tai; Zakariah Sakinah; Yusof Nor Sharina; Adil Hussein
Journal:  Cureus       Date:  2018-10-08

6.  Dacryocystitis due to sporothrix inoculated vis an unusual mode: Case report.

Authors:  Lixia Sun; Yaru Dong; Xin Wang; Baihui Shan; Min Zhang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

7.  Identification by MALDI-TOF MS of Sporothrix brasiliensis Isolated from a Subconjunctival Infiltrative Lesion in an Immunocompetent Patient.

Authors:  Aline M F Matos; Lucas M Moreira; Bianca F Barczewski; Lucas X de Matos; Jordane B V de Oliveira; Maria Ines F Pimentel; Rodrigo Almeida-Paes; Murilo G Oliveira; Tatiana C A Pinto; Nelson Lima; Magnum de O Matos; Louise G de M E Costa; Cledir Santos; Manoel Marques Evangelista Oliveira
Journal:  Microorganisms       Date:  2019-12-21

Review 8.  A One Health Approach to Combatting Sporothrix brasiliensis: Narrative Review of an Emerging Zoonotic Fungal Pathogen in South America.

Authors:  John A Rossow; Flavio Queiroz-Telles; Diego H Caceres; Karlyn D Beer; Brendan R Jackson; Jose Guillermo Pereira; Isabella Dib Ferreira Gremião; Sandro Antonio Pereira
Journal:  J Fungi (Basel)       Date:  2020-10-26

9.  Ocular adnexal sporotrichosis: A case series.

Authors:  Joaquín Felipe Ramírez-Oliveros; Regina Casz Schechtman; Henry John de Vries; Leonardo Lora; Andrea Cardoso Arinelli; José Augusto da Costa Nery; Dayvison Francis Saraiva Freitas
Journal:  JAAD Case Rep       Date:  2021-04-28

10.  Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports.

Authors:  Y Zhang; F Hagen; B Stielow; A M Rodrigues; K Samerpitak; X Zhou; P Feng; L Yang; M Chen; S Deng; S Li; W Liao; R Li; F Li; J F Meis; J Guarro; M Teixeira; H S Al-Zahrani; Z Pires de Camargo; L Zhang; G S de Hoog
Journal:  Persoonia       Date:  2015-01-29       Impact factor: 11.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.